25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions
Current Oncology Reports（2022）
关键词
Adjuvant, Melanoma, Lymph node, Resected, Overall survival, Recurrence-free survival, Immunotherapy, Checkpoint, Targeted therapy, PD-L1, AJCC, Pembrolizumab, Nivolumab, Ipilimumab, Interferon, BRAF, Dabrafenib, Trametinib, Biomarkers, Toxicity, Adverse events
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要